SCSC insider sells 6,738 shares at $41.27 under 10b5-1 plan
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Scansource, Inc. (SCSC) – Form 4 insider transaction
On 20 June 2025, Rachel Hayden, Senior Executive Vice President & Chief Information Officer of Scansource, Inc., filed a Form 4 disclosing a single open-market sale (Transaction Code “S”) of the company’s common stock executed under a Rule 10b5-1 sales plan adopted 20 March 2025. Hayden disposed of 6,738 shares at an average price of $41.27 per share, representing gross proceeds of roughly $278 k. Following the sale, the executive retains direct beneficial ownership of 13,174 shares of Scansource common stock.
No derivative securities were reported and no other transactions were disclosed in the filing. The transaction does not alter Hayden’s officer status, and there is no indication that the reporting person is no longer subject to Section 16 obligations; the filing was made solely to report the change in beneficial ownership.
The use of a pre-arranged 10b5-1 plan indicates the transaction was scheduled in advance, providing an affirmative defense against insider-trading allegations.
Positive
- Use of Rule 10b5-1 plan demonstrates proactive compliance with insider-trading regulations and reduces governance risk.
Negative
- Insider sale of 6,738 shares (≈$278 k) represents a reduction of the executive’s direct holdings.
Insights
TL;DR – Officer sold 6,738 SCSC shares (~$278 k) via pre-set 10b5-1 plan; retains 13,174 shares.
The Form 4 shows a modest discretionary sale by the Chief Information Officer. After the sale, Hayden still owns roughly twice the amount sold, suggesting continued alignment but a partial cash-out. The 10b5-1 framework reduces informational signaling; nevertheless, insider sales can still be viewed cautiously by some investors, especially if clustered. With no accompanying operational updates or large volume relative to float, the market impact should be limited.
TL;DR – Scheduled 10b5-1 sale: good compliance, limited governance concern.
From a governance lens, the key positive is adherence to the SEC’s refreshed 10b5-1 requirements—plan adopted >90 days prior, single trade disclosed clearly. The transaction size is not material relative to company capitalization and leaves the executive with a meaningful stake, satisfying alignment principles. No red flags emerge.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 6,738 | $41.27 | $278K |
Footnotes (1)
- F1. The transactions covered by this Form 4 have been effected pursuant to a Rule 10b5-1 Sales Plan adopted by the reporting person on March 20, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Was the transaction executed under a 10b5-1 trading plan?
Did the filing report any derivative security transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.